Dilon Completes Enrollment in MarginProbe® Pivotal Trial for Real-Time Detection of Cancer During Breast Conservation Surgery

[vc_row][vc_column][vc_column_text]New York, January 12, 2010 — Dilon Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the…

Read More